OnCusp Therapeutics
New York
About OnCusp Therapeutics
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments. It is always working to improve the largest value inflection point in the drug development value chain, believing that speeding oncology medication innovation is the most effective method to provide help and hope to cancer patients around the world. It is founded by Bing Yuan, Eric Slosberg, and Andy Fu.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $125.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2024)
- Website: oncusptx.com
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/oncusp-therapeutics-71529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.